Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-10-080477
Filing Date
2010-04-09
Accepted
2010-04-09 15:53:54
Documents
10
Period of Report
2010-04-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.htm 6-K 11798
2 NOTICE OF ANNUAL AND SPECIAL MEETING dex991.htm EX-99.1 7335
3 MANAGEMENT INFORMATION CIRCULAR DATED MARCH 26, 2010 dex992.htm EX-99.2 312797
4 INSTRUMENT OF PROXY - ANNUAL & SPECIAL MEETING MAY 11, 2010 dex993.htm EX-99.3 762
5 PROXY VOTING FORM dex994.htm EX-99.4 461
6 GRAPHIC g96466g32j34.jpg GRAPHIC 151619
7 GRAPHIC g96466g42i56.jpg GRAPHIC 164866
8 GRAPHIC g96466g73m27.jpg GRAPHIC 138825
9 GRAPHIC g96466logo-oncolytics.jpg GRAPHIC 10477
10 GRAPHIC g96466tx_pg06.jpg GRAPHIC 47050
  Complete submission text file 0001193125-10-080477.txt   1041912
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 10742610
SIC: 2834 Pharmaceutical Preparations